Iris A. Schulkens
Impact in
-
- Galectins and Cancer Biology
-
- Retinal Development and Disorders
- CRISPR and Genetic Engineering
- Glycosylation and Glycoproteins Research
- Signaling Pathways in Disease
Papers in
-
- Protein Tyrosine Phosphatases 4
- Signaling Pathways in Disease 2
- Angiogenesis and VEGF in Cancer 2
- Glycosylation and Glycoproteins Research 2
- Retinal Development and Disorders 2
-
- Galectins and Cancer Biology 7
- Co-authors
- Victor L. Thijssen (12 shared papers)Arjan W. Griffioen (11 shared papers)Roy Heusschen (4 shared papers)Kitty C. M. Castricum (7 shared papers)Hakon Leffler (2 shared papers)Iris Schmidt (2 shared papers)Anthony Vugler (1 shared paper)Wouter Beumer (2 shared papers)
- Journals
- Investigative Ophthalmology & Visual Science (2 papers)Oncotarget (1 paper)Journal of Vascular Research (1 paper)International Journal of Cancer (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)
- Partner nations
- NetherlandsUnited KingdomSweden
In The Last Decade
Iris A. Schulkens
16 papers receiving 462 citations
Peers
Comparison fields: 5 of 71
- Immunology 192
- Molecular Biology 314
- Cancer Research 60
- Ophthalmology 29
- Oncology 85
Countries citing papers authored by Iris A. Schulkens
This map shows the geographic impact of Iris A. Schulkens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris A. Schulkens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris A. Schulkens more than expected).
Fields of papers citing papers by Iris A. Schulkens
This network shows the impact of papers produced by Iris A. Schulkens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris A. Schulkens. The network helps show where Iris A. Schulkens may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris A. Schulkens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 126 | |
| 2 | 2018 | 61 | |
| 3 | 2013 | 54 | |
| 4 | 2015 | 39 | |
| 5 | 2014 | 37 | |
| 6 | 2014 | 27 | |
| 7 | 2010 | 23 | |
| 8 | 2021 | 22 | |
| 9 | 2016 | 22 | |
| 10 | 2016 | 22 | |
| 11 | QR-421a, an antisense oligonucleotide, for the treatment of retinitis pigmentosa due to USH2A exon 13 mutations | 2019 | 8 |
| 12 | 2021 | 8 | |
| 13 | 2014 | 8 | |
| 14 | 2014 | 5 | |
| 15 | 2014 | 2 | |
| 16 | QR-110 Treatment for Leber’s Congenital Amaurosis Type 10: Restoration of CEP290 mRNA Levels and Ciliation in LCA10 iPSC-Derived Optic Cups | 2017 | 1 |
About Iris A. Schulkens
Iris A. Schulkens is a scholar working on Molecular Biology, Immunology, Oncology, Obstetrics and Gynecology and Radiology, Nuclear Medicine and Imaging, having authored 16 papers that have together received 465 indexed citations. Recurring topics across this work include Galectins and Cancer Biology (7 papers), Protein Tyrosine Phosphatases (4 papers), Signaling Pathways in Disease (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Glycosylation and Glycoproteins Research (2 papers), Retinal Development and Disorders (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Immunology (192 citations), Molecular Biology (314 citations), Cancer Research (60 citations), Ophthalmology (29 citations) and Oncology (85 citations). Iris A. Schulkens has collaborated with scholars based in Netherlands, United Kingdom and Sweden. Frequent co-authors include Victor L. Thijssen, Arjan W. Griffioen, Roy Heusschen, Kitty C. M. Castricum, Hakon Leffler, Iris Schmidt, Anthony Vugler, Wouter Beumer, Ma’ayan Semo and Alejandro Garanto. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Oncotarget, Journal of Vascular Research, International Journal of Cancer and Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.